Expansion Opportunity Aenova’s ongoing site expansions in Killorglin Ireland and broader Europe, including new spray drying capabilities for amorphous solid dispersions and inhalation powders, present cross-border CDMO capacity and capability to handle larger or more complex formulations for clients seeking scalable manufacturing and advanced dosage forms.

Leadership Growth Recent leadership appointments, including a new Managing Director for the Latina sterile technologies site and a newly appointed Chief Operating Officer, indicate strategic leadership depth and potential for accelerated customer program execution, stronger governance, and clearer point-of-contact for key accounts.

Sustainability Edge Recognition for sustainability at major industry events and a continued focus on high quality, time-to-market performance align Aenova with customers prioritizing greener operations and reliable delivery, creating prospects for sustainability-conscious brands and regulated markets.

Innovation Leader Aenova ranks highly in innovative product provisioning and invests in state-of-the-art manufacturing technologies, including advanced spray drying, signaling ability to support next-generation dosage forms, specialized delivery systems, and complex formulations for pharma and nutraceuticals.

Competitive Positioning As Europe’s leading CDMO with a broad value-chain offering from development to commercial production, and with a turnover around 750 million euros, Aenova presents a compelling partner for mid-to-large pharma and contract manufacturing customers seeking integrated services, robust capacity, and regional supply security.